Gary Vincent Desir MD
Paul B. Beeson Professor of Medicine Chairman, Internal Medicine, Yale University School of Medicine
Join to View Full Profile
950 Campbell AveWest Haven, CT 06516
Phone+1 203-932-5711
Dr. Desir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Nephrology, 1986 - 1987- Yale-New Haven Medical CenterResidency, Internal Medicine, 1980 - 1984
Yale School of MedicineClass of 1980
Certifications & Licensure
CT State Medical License 1982 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- Promoting Collaborative Scholarship During the COVID-19 Pandemic Through an Innovative COVID-19 Data Explorer and Repository at Yale School of Medicine: Development an...Angela Maria Victoria-Castro, Tanima Arora, Michael Simonov, Aditya Biswas, Jameel Alausa
JMIR Formative Research. 2024-09-03 - 1 citationsRenalase peptides reduce pancreatitis severity in mice.Thomas R Kolodecik, Xiaoyu Guo, Christine A Shugrue, Xiaojia Guo, Gary V Desir
American Journal of Physiology. Gastrointestinal and Liver Physiology. 2024-09-01 - Chemical complementarity of tumor resident, T-cell receptor CDR3s and renalase-1 correlates with increased melanoma survival.Saif Zaman, Fred S Gorelick, Andrea Chrobrutskiy, Boris I Chobrutskiy, Gary V Desir
Oncotarget. 2024-08-05
Press Mentions
Yale School of Medicine Reflects on Takeaways from COVID-19 ResponseSeptember 18th, 2024- Covid Pitch Sounds an AlarmApril 1st, 2021
- Deborah Dyett Desir, MD, Joins ACR Executive Committee as SecretaryNovember 22nd, 2020
- Join now to see all
Grant Support
- New target and new therapy for severe Covid-19 and viral hyperinflammation damage: renalase and renalase agonistsBESSOR PHARMA, LLC2023–2025
- Renalase In Acute Kidney Injury: Utility As A Biomarker, And Therapeutic AgentNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Renalase Deficiency And Cardiovascular Complications Of Chronic Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- The Molecular Physiology Of RenalaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Regulation Of Glucose Homeostasis By The KV1.3 ChannelNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
- Structure, Function And Regulation Of Renal K ChannelsNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
- Function And Regulation Of CGMP Gated Renal K+ ChannelsNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2001
- Molecular Biology And Pathophysiology Of A CAMP Regulated Potassium ChannelNational Heart, Lung, And Blood Institute1996–2000
- Regualtion Of A Novel Cgmp-Gated K+ Channel In KidneyNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
